Rennova Health Adds Electronic Medication Administration Record to M2Select Electronic Health Record Product
June 03 2016 - 8:30AM
Business Wire
Rennova Health Inc. (NASDAQ:RNVA) (NASDAQ:RNVAW)
announces that its wholly owned electronic health records software
developer Medical Mime, Inc. has added electronic medication
management software to its flagship M2Select electronic health
record (EHR) product. Launched in the fourth quarter of 2015,
M2Select is sold to substance abuse treatment and behavioral health
providers.
Electronic Medication Administration Record, or eMAR, is
designed to replace paper-based medicine tracking and
reconciliation. This integrated solution makes it possible for
substance abuse centers and facilities to improve efficiencies by
eliminating a number of paper-centric processes. eMAR clearly and
simply informs physicians of all medications to be given to a
patient in an organized manner, thus improving communication
between facility staff and the pharmacy, and reducing the risk of
medication dispensing errors. Simply put, eMAR automates everything
– gathering, consolidating and presenting data with more speed and
accuracy than any manual system. eMAR also saves time and money,
and allows for better traceability and access to historical
records, which ultimately creates a higher standard of care for
resident patients.
“The ability to offer this eMAR function in our EHR software
takes us a step closer to achieving our goal of providing a fully
integrated practice management solution. In addition to efficiency
and compliance benefits, eMAR provides our customers with the
necessary tools to achieve certain accreditations that are now
required by payers,” said Seamus Lagan, CEO of Rennova. “We are
already seeing benefits to our growth strategy, with customers
electing to integrate this software product and our laboratory
services. We look forward to completing the development of
automatic charge capture and billing services to further increase
efficiencies for our customers and create a longer-term and
sustainable relationship with them.”
About Medical Mime, Inc.
Medical Mime, is a dictation-based electronic health records
(EHR) company and a wholly owned subsidiary of Rennova Health, Inc.
Medical Mime offers a suite of highly-specialized software modules
to create customized technology solutions. M2Select EHR is designed
for facilities that specialize in substance abuse treatment and
behavioral health; M2Pro EHR is for small-to-medium sized physician
practices, and M2Speak is a dictation and transcription product for
medical providers.
About Rennova Health, Inc.
Rennova Health provides industry-leading diagnostics and
supportive software solutions to healthcare providers, delivering
an efficient, effective patient experience and superior clinical
outcomes. Through an ever-expanding group of strategic brands that
work in unison to empower customers, we are creating the next
generation of healthcare. For more information, please visit
www.rennovahealth.com.
Forward-Looking Statements
This press release includes “forward-looking statements” within
the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. Actual results
may differ from expectations and, consequently, you should not rely
on these forward-looking statements as predictions of future
events. Words such as “expect,” “estimate,” “project,” “budget,”
“forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,”
“should,” “believes,” “predicts,” “potential,” “continue,” and
similar expressions are intended to identify such forward-looking
statements. These forward-looking statements involve significant
risks and uncertainties that could cause the actual results to
differ materially from the expected results. Additional information
concerning these and other risk factors are contained in the
Company’s most recent filings with the Securities and Exchange
Commission. The Company cautions readers not to place undue
reliance upon any forward-looking statements, which speak only as
of the date made. The Company does not undertake or accept any
obligation or undertaking to release publicly any updates or
revisions to any forward-looking statements to reflect any change
in their expectations or any change in events, conditions or
circumstances on which any such statement is based, except as
required by law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160603005154/en/
Rennova HealthSebastien Sainsbury,
561-666-9818ssainsbury@rennovahealth.comorInvestorsLHAKim Golodetz,
212-838-3777Kgolodetz@lhai.comorBruce Voss,
310-691-7100Bvoss@lhai.com